High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery



Status:Terminated
Conditions:Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/15/2018
Start Date:August 2013
End Date:June 2016

Use our guide to learn which trials are right for you!

A Phase II Randomized Trial Evaluating the Addition of High or Standard Intensity Radiation to Gemcitabine and Nab-paclitaxel for Locally Advanced Pancreatic Cancer

This randomized phase II trial studies how well high or standard intensity radiochemotherapy
after gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle formulation
(nab-paclitaxel) work compared with gemcitabine hydrochloride and nab-paclitaxel alone in
treating patients with pancreatic cancer that cannot be removed by surgery. Drugs used in
chemotherapy, such as gemcitabine hydrochloride and nab-paclitaxel, work in different ways to
stop the growth of tumor cells, either by killing the cells, by stopping them from dividing
or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor
cells. Drugs, such as capecitabine, may make tumor cells more sensitive to radiation therapy.
Giving radiation therapy in different ways and adding chemotherapy may kill more tumor cells.
It is not yet known whether high intensity radiochemotherapy after gemcitabine hydrochloride
and nab-paclitaxel is more effective than standard intensity radiochemotherapy after
gemcitabine hydrochloride and nab-paclitaxel or gemcitabine hydrochloride and nab-paclitaxel
alone in treating pancreatic cancer.

PRIMARY OBJECTIVES:

- I. To determine if intensified radiochemotherapy following gemcitabine and
nab-paclitaxel in patients with unresectable pancreatic cancer will show a signal for
improved 2-year overall survival (OS) from 10% to 22.5% as compared to chemotherapy with
gemcitabine and nab-paclitaxel alone.

- II. To determine if standard radiochemotherapy, following gemcitabine and
nab-paclitaxel, in patients with unresectable pancreatic cancer will show a signal for
improved 2-year OS from 10% to 22.5% as compared to chemotherapy with gemcitabine and
nab-paclitaxel alone.

SECONDARY OBJECTIVES:

- I. To evaluate patterns of failure (local and systemic progression) by SMAD family
member 4 (SMAD4) status and intensity of radiation therapy.

- II. To evaluate the impact of radiochemotherapy on OS for the subset of SMAD4 intact
patients.

- III. To evaluate adverse events associated with the treatments.

- IV. To evaluate correlation between SMAD4 status determined by immunohistochemistry
(IHC) and genetic SMAD4 status.

Patients are randomized to 1 of 3 treatment arms.

After completion of study treatment, patients are followed up at 1 month and then every 3
months.

Inclusion Criteria:

1. Histologically or cytologically proven diagnosis of adenocarcinoma of the pancreas
prior to registration

2. Tumor diameter ≤ 7 cm

3. Unresectable by radiographic criteria (pancreas protocol CT or MRI) or exploration
within 30 days prior to registration.

4. A cell block or core biopsy must be submitted for central review and analysis of SMAD4
status as soon as possible following step 1 registration.

5. No distant metastases, based upon the following minimum diagnostic workup:

- History/physical examination within 30 days prior to registration

- Whole body fluorodeoxyglucose-positron emission tomography/computerized
tomography (FDG-PET/CT) within 30 days prior to registration NOTE: If whole-body
FDG-PET/CT is not performed, CT of the chest and CT (or MRI) of abdomen and
pelvis must be obtained (imaging of abdomen and pelvis need not be repeated if
already included in pancreas protocol study)

6. Zubrod Performance Status 0-1 within 30 days prior to registration

7. Age ≥ 18;

8. Complete blood count (CBC)/differential obtained within 14 days prior to step 1
registration, with adequate bone marrow function defined as follows:

- Absolute neutrophil count (ANC) ≥ 1,500 cells/mm3

- Platelets ≥ 100,000 cells/mm3

- Hemoglobin ≥ 8.0 g/dl (NOTE: The use of transfusion or other intervention to
achieve Hgb ≥ 8.0 g/dl is acceptable)

9. Additional laboratory studies within 14 days prior to registration:

- carbohydrate antigen 19-9 (CA19-9); NOTE: in the event that a stent has been
placed and biliary obstruction has been relieved, the CA19-9 should be drawn post
stent placement

- Creatinine < 2 mg/dl; Glomerular filtration rate (GFR) > 50 mL/min (Cockroft and
Gault formula)

- Bilirubin < 1.5 x ULN

- Alanine aminotransferase (ALT) and aminotransferase (AST) ≤ 2.5 x ULN

- Activated partial thromboplastin time (aPTT), prothrombin time (PT) ≤1.2 x upper
limit of normal (ULN)

10. Patient must provide study specific informed consent prior to study entry

11. Women of childbearing potential and male participants must practice adequate
contraception during protocol treatment and for at least 6 months following treatment

12. For females of child-bearing potential, negative serum pregnancy test within 30 days
prior to registration

Exclusion Criteria:

1. More than one primary lesion

2. Prior invasive malignancy (unless disease free for a minimum of 1095 days [3 years]);
Non-melanomatous skin cancer and previous early prostate cancer that had a non-rising
prostate-specific antigen (PSA) are eligible

3. Prior systemic anti-cancer therapy for pancreatic cancer; note that prior chemotherapy
for a different cancer is allowable

4. Prior radiation therapy to the abdomen that would result in overlap of radiation
therapy fields

5. Severe, active co-morbidity, defined as follows:

- Unstable angina and/or congestive heart failure requiring hospitalization within
the last 6 months

- Transmural myocardial infarction within the last 6 months

- Acute bacterial or fungal infection requiring intravenous antibiotics at the time
of registration

- Chronic Obstructive Pulmonary Disease exacerbation or other respiratory illness
requiring hospitalization or precluding study therapy within 30 days before
registration

- Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects;
note, however, that laboratory tests for liver function and coagulation
parameters are not required for entry into this protocol

- Acquired Immune Deficiency Syndrome (AIDS) based upon current Centers for Disease
Control (CDC) definition; note, however, that HIV testing is not required for
entry into this protocol. The need to exclude patients with AIDS from this
protocol is necessary because the treatments involved in this protocol may be
significantly immunosuppressive. Protocol-specific requirements may also exclude
immuno-compromised patients

6. Pregnancy or women of childbearing potential, women who cannot discontinue
breastfeeding and men who are sexually active and not willing/able to use medically
acceptable forms of contraception; this exclusion is necessary because the treatment
involved in this study may be significantly teratogenic

7. Prior allergic reaction to the study drug(s) involved in this protocol

8. Pre-existing Grade 2 or greater neuropathy

9. Distant metastases
We found this trial at
46
sites
835 S Van Buren St
Green Bay, Wisconsin 54301
(920) 433-0111
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
593 Eddy Street
Providence, Rhode Island 02903
401-444-4000
Principal Investigator: Howard Safran
Phone: 401-444-1488
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
?
mi
from
Providence, RI
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Yuhchyau Chen
Phone: 585-275-5830
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
1 Akron General Ave
Akron, Ohio 44307
(330) 344-6000
Akron General Medical Center It
?
mi
from
Akron, OH
Click here to add this to my saved trials
1111 Duff Ave
Ames, Iowa 50010
(866) 972-5477
Principal Investigator: Joseph J. Merchant
Phone: 515-239-2621
McFarland Clinic PC-William R Bliss Cancer Center The William R. Bliss Cancer Center at Mary...
?
mi
from
Ames, IA
Click here to add this to my saved trials
5301 McAuley Drive
Ann Arbor, Michigan 48197
734-712-3456
Principal Investigator: Samir Narayan
Phone: 734-712-4673
Saint Joseph Mercy Hospital St. Joseph Mercy Ann Arbor Hospital is a 537-bed teaching hospital...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
401 North Broadway
Baltimore, Maryland 21287
410-955-5000
Principal Investigator: Joseph M. Herman
Phone: 410-955-8804
Johns Hopkins University-Sidney Kimmel Cancer Center The name Johns Hopkins has become synonymous with excellence...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
1300 Anne Street NW
Bemidji, Minnesota 56601
(218) 751-5430
Principal Investigator: Preston D. Steen
Phone: 701-234-6161
Sanford Clinic North-Bemidgi Sanford Health is a voluntary, not-for-profit health care organization. Through its entities,...
?
mi
from
Bemidji, MN
Click here to add this to my saved trials
Berlin, Vermont 05602
Principal Investigator: Christopher J. Anker
Phone: 802-656-4101
?
mi
from
Berlin, VT
Click here to add this to my saved trials
300 N. Seventh St.
Bismarck, North Dakota 58501
(701) 323-6000
Principal Investigator: Preston D. Steen
Phone: 701-234-6161
Sanford Bismarck Medical Center Whether your stay in our hospital is one day for same...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Boston, Massachusetts 02118
Principal Investigator: Lisa A. Kachnic
Phone: 617-638-8265
?
mi
from
Boston, MA
Click here to add this to my saved trials
130 S Bryn Mawr Ave
Bryn Mawr, Pennsylvania 19010
(484) 337-3000
Bryn Mawr Hospital Bryn Mawr Hospital, a nationally recognized community teaching hospital, is conveniently located...
?
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Burlington, Vermont 05405
Principal Investigator: Christopher J. Anker
Phone: 802-656-4101
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Chicago, Illinois 60657
Principal Investigator: Nicholas S. Galanopoulos
Phone: 773-665-3109
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2300 N Edward St
Decatur, Illinois 62526
(217) 876-8121
Principal Investigator: James L. Wade
Phone: 217-876-4740
Decatur Memorial Hospital An American flag bearing only 48 stars waved above Decatur Memorial Hospital...
?
mi
from
Decatur, IL
Click here to add this to my saved trials
1200 Pleasant St
Des Moines, Iowa 50309
(515) 241-6212
Principal Investigator: Robert J. Behrens
Phone: 515-282-2921
Iowa Methodist Medical Center Iowa Methodist Medical Center was established in 1901 in a single...
?
mi
from
Des Moines, IA
Click here to add this to my saved trials
820 4th St N
Fargo, North Dakota 58102
(701) 234-6161
Principal Investigator: Preston D. Steen
Phone: 701-234-6161
Roger Maris Cancer Center Sanford Health is an integrated health system headquartered in the Dakotas...
?
mi
from
Fargo, ND
Click here to add this to my saved trials
Fort Wayne, Indiana 46804
Principal Investigator: Brian K. Chang
Phone: 260-373-8888
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
2200 Randallia Drive
Fort Wayne, Indiana 46805
Principal Investigator: Brian K. Chang
Phone: 260-373-8888
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
1726 Shawano Ave
Green Bay, Wisconsin 54303
(920) 498-4200
Saint Mary's Hospital Our team of dedicated physicians, nurses and staff offer a broad spectrum...
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Christopher H. Crane
Phone: 713-792-3245
?
mi
from
Houston, TX
Click here to add this to my saved trials
1915 White Ave.
Knoxville, Tennessee 37916
(865) 541-1678
Principal Investigator: Daniel D. Scaperoth
Phone: 865-541-1812
Thompson Cancer Survival Center The Thompson Cancer Survival Center Downtown facility has pioneered many advances...
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
3100 Shore Drive
Marinette, Wisconsin 54143
715.735.4200
Bay Area Medical Center Bay Area Medical Center was created in 1985, but its history...
?
mi
from
Marinette, WI
Click here to add this to my saved trials
175 Madison Avenue
Mount Holly, New Jersey 08060
(609) 914-6000
Principal Investigator: Lemuel S. Ariaratnam
Phone: 888-847-8823
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Virtua Memorial is a...
?
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
5121 S Cottonwood St
Murray, Utah 84157
(801) 507-7000
Principal Investigator: Jeffrey E. Lee
Phone: 713-792-3245
Intermountain Medical Center Intermountain Medical Center is one of the most technologically advanced and patient-friendly...
?
mi
from
Murray, UT
Click here to add this to my saved trials
New Orleans, Louisiana 70121
Principal Investigator: Mini J. Elnaggar
Phone: 888-562-4763
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oakland, California 94611
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Ogden, Utah 84403
Principal Investigator: Jeffrey E. Lee
Phone: 713-792-3245
?
mi
from
Ogden, UT
Click here to add this to my saved trials
255 W Lancaster Ave
Paoli, Pennsylvania 19301
(484) 565-1000
Paoli Memorial Hospital Paoli is recognized regionally and nationally for outstanding medical and surgical services,...
?
mi
from
Paoli, PA
Click here to add this to my saved trials
Pennington, New Jersey 08534
?
mi
from
Pennington, NJ
Click here to add this to my saved trials
Peoria, Illinois 61615
Principal Investigator: James L. Wade
Phone: 217-876-4740
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Peoria, Illinois 61637
Principal Investigator: James L. Wade
Phone: 217-876-4740
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Michael G. Haddock
Phone: 507-538-7623
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Louis, Missouri 63141
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
2000 Circle of Hope Dr
Salt Lake City, Utah 84112
(801) 585-0303
Principal Investigator: Jonathan D. Tward
Phone: 801-581-4477
Huntsman Cancer Institute at University of Utah Huntsman Cancer Institute (HCI) is part of the...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
700 Lawrence Expy
Santa Clara, California 95051
(408) 851-1000
Kaiser Permanente Medical Center - Santa Clara At Kaiser Permanente Santa Clara, members and patients...
?
mi
from
Santa Clara, CA
Click here to add this to my saved trials
1305 W 18th St
Sioux Falls, South Dakota 57117
(605) 333-1000
Principal Investigator: Preston D. Steen
Phone: 701-234-6161
Sanford USD Medical Center - Sioux Falls Sanford
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
South San Francisco, California 94080
?
mi
from
South San Francisco, CA
Click here to add this to my saved trials
1235 E Cherokee St
Springfield, Missouri 65804
(417) 820-2000
Mercy Hospital Springfield We're continuing a tradition of healing more than 120 years old. Mercy...
?
mi
from
Springfield, MO
Click here to add this to my saved trials
3801 South National Avenue
Springfield, Missouri 65807
(417) 269-6000
Principal Investigator: Jay W. Carlson
Phone: 800-821-7532
CoxHealth South Hospital U.S. News & World Report has ranked CoxHealth one of Missouri's best...
?
mi
from
Springfield, MO
Click here to add this to my saved trials
Sturgeon Bay, Wisconsin 54235
?
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
300 South 6th Avenue
West Reading, Pennsylvania 19611
(610) 988-8000
Principal Investigator: Michael L. Haas
Phone: 610-988-9323
Reading Hospital At Reading Health System, advancing your health and wellness is our mission. When...
?
mi
from
West Reading, PA
Click here to add this to my saved trials
301 Becker Ave SW
Willmar, Minnesota 56201
(320) 235-4543
Principal Investigator: Paul W. Sperduto
Phone: 952-993-1517
Rice Memorial Hospital Rice Memorial Hospital is a Level 3 Trauma Center and the largest...
?
mi
from
Willmar, MN
Click here to add this to my saved trials
Wynnewood, Pennsylvania 19096
?
mi
from
Wynnewood, PA
Click here to add this to my saved trials